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Simoneau et al 1 reported the clinical usefulness of blood cultures in the diagnosis of invasive aspergillosis, stating 'even in a population at highest risk for invasive aspergillosis, positive blood cultures with Aspergillus sp. remain unusual, and cannot be readily associated with invasive aspergillosis. ' We agree with their opinion and hereby report our data.
We reviewed autopsy results of 720 patients with hematologic malignancies treated between 1980 and 1990.
2 Invasive aspergillosis was pathologically diagnosed in 91 patients. While blood cultures were obtained median 3 times (range, 1-19 times) from each patient, Aspergillus fungemia was identified in only one patient. Intravenous amphotericin B had been administered to 61 patients before death. Since 2000, we have obtained blood specimens for Aspergillus antigen test using enzyme-linked immunosorbent assay (Platelia Aspergillus, Bio Rad), beta-D-glucan assay (Fungi-Tec, Seikagaku Corporation, Tokyo, Japan), and polymerase chain reaction (PCR) using Aspergillusspecific primers to make an early diagnosis of invasive aspergillosis. Their sensitivities were 79, 58, and 67%, respectively. 3 The sensitivity of Aspergillus blood culture is by far the lowest among these blood tests.
Aspergillus hyphae may be difficult to proliferate in a blood culture bottle. We investigated the sensitivity of each test in vitro in detecting circulating Aspergillus components. 4 Aspergillus fumigatus was cultured in Sabouraud medium at 371 for 3 days. The culture medium 100 ml was serially diluted with blood obtained from a healthy donor in the ratio of 1:10. All the diluted samples were subjected to blood culture, Aspergillus antigen test, beta-D-glucan assay, and PCR. Results were shown in Table 1 . We have partly reported the results. 4 The observations lead to two hypotheses. First, some substances in the patients' blood might interfere with the detection of Aspergillus in blood culture. We cannot exclude the possibility that amphotericin B inhibits the growth of Aspergillus hyphae, as the detection of candidemia is lowered by the use of fluconazole.
2 However, our observations cannot be fully explained by this theory, since amphotericin B had not been used in 30 patients.
Second, only detached components of the hyphae may circulate in the blood stream of patients with invasive aspergillosis, since viable Aspergillus hyphae infrequently enter the circulation. When viable Aspergillus exists in the blood stream, blood culture can detect it with low sensitivity (Table 1 ). However, even in patients with disseminated aspergillosis, the rate of positive blood cultures is low. As Simoneau et al 1 described, Aspergillus hyphae are endocytosed by the blood vessel endothelial cells causing progressive endothelial injury and thrombosis. Although blood cultures can grow only viable Aspergillus hyphae, endocytosed hyphae could maintain considerably impaired viability and would not be yielded in blood cultures. This hypothesis can reasonably explain the dissociation between blood culture and Aspergillus antigen tests in disseminated aspergillosis, and the dissociation between cerebrospinal fluid culture and the antigen test in central nervous system aspergillosis. 5, 6 It can also explain that the sensitivity of PCR is not superior to that of the antigen test. 7 In patients with Aspergillus infection, the lesion in the lung might provide fungal components into the blood stream continuously or intermittently. It is reasonable to assume that viable Aspergillus hyphae from which fungal gene can be extracted less frequently circulate in the blood stream than do hyphal components containing antigenic sites. We need to be alert to the characteristics and limitations of Aspergillus antigen tests, PCR, and blood culture in the diagnosis of Aspergillus infection. 
